Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Jedrzejek DavidSVP and General Counsel | Grant or award | A | — 10.4K sh | Jan 26, 2026 |
| 9 | Kroll Lara JSVP & Chief Accounting Officer | Tax withholding | F | $32K 340 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Burton Eve BDirector | Grant or award | A | $28K 49 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Roslansky RyanDirector | Option exercise | M | — 469 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $471K 3,603 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Zaeske Adam H.CHIEF COMMERCIAL OFFICER | Grant or award | A | — 16.2K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Mawakana TekedraDirector | Option exercise | M | — 694 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Yuan Eric S.Director | Grant or award | A | — 497 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Scott Stuart LockardEVP/CIO | Grant or award | A | — 4,110 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Dalzell Richard LDirector | Option exercise | M | $31K 82 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Serafin AndrewCHIEF STRATEGY OFFICER | Option exercise | M | — 2,500 sh | Jan 26, 2026 traded Jan 24, 2026 |
| 9 | Heilbronn FrancoisDirector | Option exercise | M | — 375 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Nora Johnson Suzanne MDirector | Option exercise | M | — 586 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Jarrett JenniferChief Operating Officer | Grant or award | A | — 126.0K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Norrod Forrest EugeneDirector | Grant or award | A | — 497 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Kapadia SandipCHIEF FINANCIAL OFFICER | Option exercise | M | — 4,725 sh | Jan 26, 2026 traded Jan 25, 2026 |
| 9 | Goeltz II Robert C.Chief Financial Officer | Grant or award | A | — 96.0K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Szkutak Thomas JDirector | Option exercise | M | $25K 67 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Nora Johnson Suzanne MDirector | Option exercise | M | — 694 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $471K 3,604 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Roslansky RyanDirector | Option exercise | M | — 407 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Heilbronn FrancoisDirector | Option exercise | M | — 375 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Serafin AndrewCHIEF STRATEGY OFFICER | Grant or award | A | — 42.6K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Nora Johnson Suzanne MDirector | Option exercise | M | — 694 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Ahlstrom PaulDirector | Option exercise | M | — 2,648 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Budur KumarCHIEF MEDICAL OFFICER | Grant or award | A | — 42.6K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Pelosi PeggieDirector | Option exercise | M | — 1,058 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Budur KumarCHIEF MEDICAL OFFICER | Option exercise | M | — 2,662 sh | Jan 26, 2026 traded Jan 25, 2026 |
| 9 | Serafin AndrewCHIEF STRATEGY OFFICER | Grant or award | A | — 12.2K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Budur KumarCHIEF MEDICAL OFFICER | Tax withholding | F | $42K 1,153 sh | Jan 26, 2026 traded Jan 24, 2026 |
| 9 | Cohlhepp RyanDirector, President and COO | Open-market sale · 10b5-1 plan | SELL | $69K 3,828 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Dalzell Richard LDirector | Option exercise | M | — 694 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Roslansky RyanDirector | Option exercise | M | — 418 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Nora Johnson Suzanne MDirector | Option exercise | M | — 880 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Feehan MichaelSee Remarks | Tax withholding | F | $46K 4,246 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $376K 2,861 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Teo GaryExecutive Vice President | Option exercise | M | — 29 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Nora Johnson Suzanne MDirector | Option exercise | M | — 880 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Nora Johnson Suzanne MDirector | Option exercise | M | — 663 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Szkutak Thomas JDirector | Option exercise | M | $25K 67 sh | Jan 26, 2026 traded Jan 22, 2026 |